AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Synergy Vaccines announces issuance of U.S. patent for SynerVax technology.(Brief Article)
2002 JUL 17 - (NewsRx.com & NewsRx.net) -- Synergy Vaccines, Inc., announced issuance of U.S. Patent No. 6,403,092, entitled "Immune Response Modulator Alpha-2- Macroglobulin Complex" to Duke University, Durham, North Carolina, for inventions created by two of its Medical Center employees, Drs. Salvatore Pizzo and Hanne Gron.
As the exclusive licensee of worldwide rights to the technology disclosed in this patent, Synergy strengthens its position in the vaccine market through the usage of the complexes of antigens and alpha-2-macroglobulin (SynerVax adjuvant) as vaccine candidates.
Synergy Vaccines is currently evaluating the use of the SynerVax adjuvant system with a wide variety of vaccine candidates including preventive vaccines for AIDS, infectious diseases and biological agents as well as therapeutic vaccines for cancer, Alzheimer's' disease and hepatitis. This research is being conducted both by Synergy and in collaboration with a number of academic and industry investigators. Antigens complexed within SynerVax adjuvant have been shown to be much more immunogenic than antigens ...
- Synergy Vaccines Reaches Milestone with SynerVax-HB Hepatitis Vaccine.(Brief...
- Newspaper article from: Vaccine Weekly December 12, 2001 700+ words
...that HBsAg formulated in SynerVax adjuvant elicits antibodies in mice...extremely low concentrations. SynerVax adjuvant, Synergy Vaccines' proprietary vaccine adjuvant...and Dr. Hanne Gron. The SynerVax adjuvant technology has been licensed...
- Synergy Vaccines Reaches Milestone with SynerVax-HB Hepatitis Vaccine.
- Newspaper article from: Hepatitis Weekly December 10, 2001 700+ words
...that HBsAg formulated in SynerVax adjuvant elicits antibodies in mice...extremely low concentrations. SynerVax adjuvant, Synergy Vaccines' proprietary vaccine adjuvant...and Dr. Hanne Gron. The SynerVax adjuvant technology has been licensed...
- Synergy Vaccines announces issuance of alpha-2-macroglobulin complex...
- Newspaper article from: BIOTECH Patent News June 1, 2002 700+ words
...Macroglobulin (SynerVax adjuvant) as vaccine candidates. Synergy Vaccines is currently...use of the SynerVax adjuvant system with...responses." Synergy Vaccines is a biopharmaceutical...vaccines using SynerVax adjuvant technology...
- Synergy Vaccines announces issuance of U.S. patent for SynerVax technology.
- Newspaper article from: Hepatitis Weekly July 15, 2002 700+ words
...NewsRx.net) -- Synergy Vaccines, Inc., announced...2-macroglobulin (SynerVax adjuvant) as vaccine candidates. Synergy Vaccines is currently evaluating the use of the SynerVax adjuvant system with a wide variety...
- Synergy Vaccines /.
- Press release article from: PR Newswire April 12, 2001 700+ words
In CHTU018, "Synergy Vaccines Announces Collaboration with...April 10, we are advised by Synergy Vaccines of numerous changes to the release...SOURCE of the release should be Synergy Vaccines rather than BD Technologies...
- Synergy Vaccines Announces Issuance of US Patent for SynerVax(TM) Technology.
- Press release article from: PR Newswire June 12, 2002 700+ words
...RESEARCH TRIANGLE PARK, N.C. -- Synergy Vaccines, Inc. announced today that the United...adjuvant) as vaccine candidates. Synergy Vaccines is currently evaluating the use of...initiating protective immune responses." Synergy Vaccines, Inc. is a biopharmaceutical company...
- Synergy Vaccines Reaches Milestone with SynerVax(TM)-HB Hepatitis Vaccine.
- Press release article from: PR Newswire November 12, 2001 700+ words
...formulated in SynerVax(TM) adjuvant elicits antibodies in mice at extremely low concentrations. SynerVax(TM) adjuvant, Synergy Vaccines' proprietary vaccine adjuvant, is based on the plasma protein alpha2-Macroglobulin and was developed at DUMC by Dr...
- SYNERGY VACCINES DEVELOPING FORMULATIONS FOR HIV, CANCER.
- Magazine article from: BIOWORLD Today Willett, Matthew April 16, 2001 700+ words
BD Technologies' start-up Synergy Vaccines Inc. is developing formulations designed to improve the efficacy of vaccines for life- threatening diseases such as HIV and cancer...
